Announcement of New Chief Chemistry Officer
Awarded the Special Jury Prize at Institute of Science Tokyo Venture Contest | IOI & SS 2025
Announcement of Participation in the “upto4 × MIRAISOZO INVESTMENTS Technology Seeds Matching Event”
Announcement of Our Upcoming Pitch Presentation （IOISS 2025）
Announcement of New CTO and CBO Appointment
Innovative mRNA Drug
Development Technology
mRNA vaccines and medicines have attracted significant attention in recent years. We can design and synthesize high-quality mRNA through our science and technology. We will contribute to the development of innovative medicines by collaborating with various partners.
Creating the Future with our proprietary Technology
Our aim is to develop new medicines for diseases with unmet medical needs by enhancing our proprietary mRNA platform technology through collaborations with academia and pharmaceutical companies.
To achieve this objective, we will partner with various stakeholders to break down barriers between disciplines, divisions, and cultures, and fearlessly tackle challenging obstacles to expedite the delivery of innovative medicines.
